Detailed price information for Nervgen Pharma Corp (NGENF) from The Globe and Mail including charting and trades.

Working full-time and having insurance has not insulated Ashaki Sypher's family from teetering on financial collapse. Her ...

The Global Spinal Implants And Surgery Devices Market Size projected to grow at a CAGR of 4.3% from 2026 to 2032, according ...

Venom of the scorpion Brotheas amazonicus appears to attack breast cancer cells in a way similar to a widely used ...

The Veterans With ALS Reporting Act seeks to develop strategies for lowering the potential risks for ALS, commonly known as ...

Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression in ...

Strengthening U.S. Biomanufacturing Presence through ARMI/BioFabUSA During Q3 2025, NurExone joined the ARMI/BioFabUSA BioFab Startup Lab, gaining access to a leading U.S. ecosystem dedicated to ...

Stem cells play a central role in regenerative medicine, since they possess the capacity for self renewal and the ability to ...

For more than a century, scientists have wrestled with a deceptively simple question: how do you cool living tissue to ...

Few nursing homes can care for people who need help breathing with a ventilator because of ALS and other conditions. Insurers ...

If you’re dealing with persistent, unexplained symptoms like sharp pain, chronic numbness or noticeable muscle weakness, ...

NervGen will meet with the FDA early next year to align on a regulatory path forward for NVG-291 in chronic spinal cord ...